522 related articles for article (PubMed ID: 30472720)
21. Long noncoding RNA CPS1-IT1 suppresses the metastasis of hepatocellular carcinoma by regulating HIF-1α activity and inhibiting epithelial-mesenchymal transition.
Wang TH; Yu CC; Lin YS; Chen TC; Yeh CT; Liang KH; Shieh TM; Chen CY; Hsueh C
Oncotarget; 2016 Jul; 7(28):43588-43603. PubMed ID: 27248828
[TBL] [Abstract][Full Text] [Related]
22. Long non-coding RNA AOC4P suppresses hepatocellular carcinoma metastasis by enhancing vimentin degradation and inhibiting epithelial-mesenchymal transition.
Wang TH; Lin YS; Chen Y; Yeh CT; Huang YL; Hsieh TH; Shieh TM; Hsueh C; Chen TC
Oncotarget; 2015 Sep; 6(27):23342-57. PubMed ID: 26160837
[TBL] [Abstract][Full Text] [Related]
23. LncRNA LINC00668 promotes cell proliferation, migration, invasion ability and EMT process in hepatocellular carcinoma by targeting miR-532-5p/YY1 axis.
Xuan W; Zhou C; You G
Biosci Rep; 2020 May; 40(5):. PubMed ID: 32249890
[TBL] [Abstract][Full Text] [Related]
24. LINC00511 as a ceRNA promotes cell malignant behaviors and correlates with prognosis of hepatocellular carcinoma patients by modulating miR-195/EYA1 axis.
Hu WY; Wei HY; Li KM; Wang RB; Xu XQ; Feng R
Biomed Pharmacother; 2020 Jan; 121():109642. PubMed ID: 31731191
[TBL] [Abstract][Full Text] [Related]
25. Silencing of a novel lncRNA LOC105369748 suppresses the progression of hepatocellular carcinoma by sponging miR-5095 from MBD2.
E C; Li C; Li H; Yang J
J Cell Physiol; 2019 Aug; 234(10):18504-18512. PubMed ID: 30912130
[TBL] [Abstract][Full Text] [Related]
26. LncRNA CACNA1G-AS1 facilitates hepatocellular carcinoma progression through the miR-2392/C1orf61 pathway.
Yang J; Li C; Li H; E C
J Cell Physiol; 2019 Aug; 234(10):18415-18422. PubMed ID: 30908634
[TBL] [Abstract][Full Text] [Related]
27. The long noncoding RNA AK002107 negatively modulates miR-140-5p and targets TGFBR1 to induce epithelial-mesenchymal transition in hepatocellular carcinoma.
Tang YH; He GL; Huang SZ; Zhong KB; Liao H; Cai L; Gao Y; Peng ZW; Fu SJ
Mol Oncol; 2019 May; 13(5):1296-1310. PubMed ID: 30943320
[TBL] [Abstract][Full Text] [Related]
28. A long non-coding RNA lncRNA-PE promotes invasion and epithelial-mesenchymal transition in hepatocellular carcinoma through the miR-200a/b-ZEB1 pathway.
Shen Y; Liu S; Yuan H; Ying X; Fu H; Zheng X
Tumour Biol; 2017 May; 39(5):1010428317705756. PubMed ID: 28488544
[TBL] [Abstract][Full Text] [Related]
29. LncRNA TUG1 interacting with miR-144 contributes to proliferation, migration and tumorigenesis through activating the JAK2/STAT3 pathway in hepatocellular carcinoma.
Lv J; Kong Y; Gao Z; Liu Y; Zhu P; Yu Z
Int J Biochem Cell Biol; 2018 Aug; 101():19-28. PubMed ID: 29791864
[TBL] [Abstract][Full Text] [Related]
30. XIST Induced by JPX Suppresses Hepatocellular Carcinoma by Sponging miR-155-5p.
Lin XQ; Huang ZM; Chen X; Wu F; Wu W
Yonsei Med J; 2018 Sep; 59(7):816-826. PubMed ID: 30091314
[TBL] [Abstract][Full Text] [Related]
31. The long noncoding RNA NEAT1 contributes to hepatocellular carcinoma development by sponging miR-485 and enhancing the expression of the STAT3.
Zhang XN; Zhou J; Lu XJ
J Cell Physiol; 2018 Sep; 233(9):6733-6741. PubMed ID: 29219178
[TBL] [Abstract][Full Text] [Related]
32. Long non-coding RNA UCA1 regulates the expression of Snail2 by miR-203 to promote hepatocellular carcinoma progression.
Xiao JN; Yan TH; Yu RM; Gao Y; Zeng WL; Lu SW; Que HX; Liu ZP; Jiang JH
J Cancer Res Clin Oncol; 2017 Jun; 143(6):981-990. PubMed ID: 28271214
[TBL] [Abstract][Full Text] [Related]
33. LncRNA FAL1 promotes cell proliferation and migration by acting as a CeRNA of miR-1236 in hepatocellular carcinoma cells.
Li B; Mao R; Liu C; Zhang W; Tang Y; Guo Z
Life Sci; 2018 Mar; 197():122-129. PubMed ID: 29421439
[TBL] [Abstract][Full Text] [Related]
34. Downregulation of long noncoding RNA CRNDE suppresses drug resistance of liver cancer cells by increasing microRNA-33a expression and decreasing HMGA2 expression.
Han S; Han B; Li Z; Sun D
Cell Cycle; 2019 Oct; 18(19):2524-2537. PubMed ID: 31416393
[TBL] [Abstract][Full Text] [Related]
35. LncRNA HCG11 accelerates the progression of hepatocellular carcinoma via miR-26a-5p/ATG12 axis.
Li ML; Zhang Y; Ma LT
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10708-10720. PubMed ID: 31858580
[TBL] [Abstract][Full Text] [Related]
36. Long non‑coding RNA MKLN1‑AS aggravates hepatocellular carcinoma progression by functioning as a molecular sponge for miR‑654‑3p, thereby promoting hepatoma‑derived growth factor expression.
Gao W; Chen X; Chi W; Xue M
Int J Mol Med; 2020 Nov; 46(5):1743-1754. PubMed ID: 33000222
[TBL] [Abstract][Full Text] [Related]
37. LINC00460 promotes hepatocellular carcinoma development through sponging miR-485-5p to up-regulate PAK1.
Tu J; Zhao Z; Xu M; Chen M; Weng Q; Ji J
Biomed Pharmacother; 2019 Oct; 118():109213. PubMed ID: 31376654
[TBL] [Abstract][Full Text] [Related]
38. LncRNA KTN1-AS1 promotes tumor growth of hepatocellular carcinoma by targeting miR-23c/ERBB2IP axis.
Zhang L; Wang L; Wang Y; Chen T; Liu R; Yang W; Liu Q; Tu K
Biomed Pharmacother; 2019 Jan; 109():1140-1147. PubMed ID: 30551364
[TBL] [Abstract][Full Text] [Related]
39. lncRNA MIAT promotes proliferation and invasion of HCC cells via sponging miR-214.
Huang X; Gao Y; Qin J; Lu S
Am J Physiol Gastrointest Liver Physiol; 2018 May; 314(5):G559-G565. PubMed ID: 29097358
[TBL] [Abstract][Full Text] [Related]
40. LncRNA SNHG3 Promotes Hepatocellular Tumorigenesis by Targeting miR-326.
Zhao Q; Wu C; Wang J; Li X; Fan Y; Gao S; Wang K
Tohoku J Exp Med; 2019 Sep; 249(1):43-56. PubMed ID: 31548493
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
